Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | APAF1 | O14727 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.51 |
| ▸ | FDPS | P14324 | 17/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29271983 | 0.98 | MEN1 (0.56) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL4358561 | 0.98 | MEN1 (0.56) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Bromide SCHEMBL4364814 | 0.98 | MEN1 (0.56) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL2693557 | 0.98 | MEN1 (0.56) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL15901605 | 0.98 | MEN1 (0.56) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL23698402 | 0.98 | MEN1 (0.56) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL28548851 | 0.98 | MEN1 (0.56) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL3398652 | 0.98 | MEN1 (0.56) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Iodide SCHEMBL15008778 | 0.98 | MEN1 (0.52) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Bromide SCHEMBL15901519 | 0.97 | MEN1 (0.55) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117866290-A | Antistatic agent based on ionic compound exchange reaction and preparation method thereof | 浙江东吴新材料股份有限公司 | 2024-04-12 | — | — | CN | claimed |
| US-9018777-B2 | Light-emitting-element encapsulating composition, light-emitting diode and liquid crystal display device | LG CHEM, LTD. (KR) | 2015-04-28 | — | — | US | claimed |
| US-20140185274-A1 | LIGHT-EMITTING-ELEMENT ENCAPSULATING COMPOSITION, LIGHT-EMITTING DIODE AND LIQUID CRYSTAL DISPLAY DEVICE | LG CHEM, LTD. (KR) | 2014-07-03 | — | — | US | claimed |
| US-8716395-B2 | Light-emitting-element encapsulating composition, light-emitting diode and liquid-crystal display device | LG CHEM, LTD. (KR) | 2014-05-06 | — | — | US | claimed |
| US-20120168781-A1 | LIGHT-EMITTING-ELEMENT ENCAPSULATING COMPOSITION, LIGHT-EMITTING DIODE AND LIQUID-CRYSTAL DISPLAY DEVICE | LG CHEM LTD. (KR) | 2012-07-05 | — | — | US | claimed |
| EP-2458594-A2 | LIGHT-EMITTING-ELEMENT ENCAPSULATING COMPOSITION, LIGHT-EMITTING DIODE AND LIQUID-CRYSTAL DISPLAY DEVICE | LG Chem, Ltd. (KR) | 2012-05-30 | — | — | EP | claimed |
| EP-2458594-B1 | LIGHT-EMITTING-ELEMENT ENCAPSULATING COMPOSITION, LIGHT-EMITTING DIODE AND LIQUID-CRYSTAL DISPLAY DEVICE | LG CHEMICAL LTD (KR) | 2018-01-10 | — | — | EP | disclosed |
| US-20160181664-A1 | ELECTROLYTE FOR SODIUM ION SECONDARY BATTERY | TOYO GOSEI CO., LTD. (JP) | 2016-06-23 | — | — | US | disclosed |
| US-9018777-B2 | Light-emitting-element encapsulating composition, light-emitting diode and liquid crystal display device | LG CHEM, LTD. (KR) | 2015-04-28 | — | — | US | disclosed |
| US-20140185274-A1 | LIGHT-EMITTING-ELEMENT ENCAPSULATING COMPOSITION, LIGHT-EMITTING DIODE AND LIQUID CRYSTAL DISPLAY DEVICE | LG CHEM, LTD. (KR) | 2014-07-03 | — | — | US | disclosed |
| EP-1721900-B1 | NOVEL IMIDAZOLIUM COMPOUND | KANTO KAGAKU (JP) | 2014-06-11 | — | — | EP | disclosed |
| US-8716395-B2 | Light-emitting-element encapsulating composition, light-emitting diode and liquid-crystal display device | LG CHEM, LTD. (KR) | 2014-05-06 | — | — | US | disclosed |
| US-20120168781-A1 | LIGHT-EMITTING-ELEMENT ENCAPSULATING COMPOSITION, LIGHT-EMITTING DIODE AND LIQUID-CRYSTAL DISPLAY DEVICE | LG CHEM LTD. (KR) | 2012-07-05 | — | — | US | disclosed |
| US-7731762-B2 | Dye composition and dyeing method | FUJIFILM CORPORATION (JP) | 2010-06-08 | — | — | US | disclosed |
| EP-2159242-A1 | SEALING AGENT FOR OPTICAL SEMICONDUCTOR ELEMENT, AND OPTICAL SEMICONDUCTOR ELEMENT | Sekisui Chemical Co., Ltd. (JP) | 2010-03-03 | — | — | EP | disclosed |
| US-7517999-B2 | needs no complicated operations for dissolution and has excellent handleability and a high ionic conductivity, electrolytes; 1-butyl-3-allylimidazolium bromide | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2009-04-14 | — | — | US | disclosed |
| US-20090021558-A1 | Liquid discharge apparatus and method for producing liquid discharge apparatus | BROTHER KOGYO KABUSHIKI KAISHA | 2009-01-22 | — | — | US | disclosed |
| US-20090020327-A1 | Wiring unit, method for producing wiring unit, liquid jetting apparatus, and method for producing liquid jetting apparatus | BROTHER KOGYO KABUSHIKI KAISHA | 2009-01-22 | — | — | US | disclosed |
| US-20070191612-A1 | Needs no complicated operations for dissolution and has excellent handleability and a high ionic conductivity, electrolytes; 1-butyl-3-allylimidazolium bromide | HIROYUKI OHNO (JP) | 2007-08-16 | — | — | US | disclosed |
| EP-1721900-A1 | NOVEL IMIDAZOLIUM COMPOUND | Kanto Kagaku Kabushiki Kaisha (JP) | 2006-11-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191612-A1 | Needs no complicated operations for dissolution and has excellent handleability and a high ionic conductivity, electrolytes; 1-butyl-3-allylimidazolium bromide | SLC26A3, KCNJ11, SLC26A4 | MEN1 636/4885HSP90AA1 3528/4885KMT2A 4733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.